Surgeon and Female Doctor Walk Through Hospital Hallway

EY financial advisor to the shareholders of Premicare

EY acted as financial advisor to the shareholders of Premicare in their sale to Prima Vård.

Premicare, a privately owned Swedish primary care provider with nine clinics and almost 60,000 listed patients, was acquired by the Nordstjernan backed healthcare provider Prima Vård. The acquisition strengthens Prima’s position as one of the largest providers of healthcare across Sweden.

 

Premicare was founded in the mid-2000s and employs approximately 230 people including e.g. doctors, nurses, psychologists, rehab specialists, physiotherapists, occupational therapists, child healthcare professionals and midwives. Premicare offers extensive coverage and availability through a wide range of healthcare services, including both physical and digital healthcare visits.

 

EY Corporate Finance’s team in the Health, Sciences & Wellness sector acted as financial advisers to the owners of Premicare. The transaction demonstrates EY’s strong position in the primary care and broader healthcare market in the Nordics with several mid-sized transactions completed in the sector with EY as advisor. EY’s Transaction Diligence team also supported Premicare with a comprehensive data book and EY Law acted as legal advisor to Premicare’s shareholders.

 

The M&A team consisted of Staffan Folin (EP), Victor Svensson (EM) and Karin Asp.

 

The Transaction Diligence team consisted of Alberico De Lisa and Oskar Duan.

 

The EY Law team consisted of Anett Lilliehöök, Björn Bjurström, Victoria Karlsson and Mattias Bengtsson.

 

Learn more of the transaction here.

 

Below you can find a selection of EY's recent deal alerts and you can also find a more extensive list on our Strategy and Transactions page.

Related deal alerts

EY advisor to the shareholders of Cevitagruppen and DBI Vård & Hälsa

EY acted as financial advisor to the shareholders of Cevitagruppen and DBI Vård & Hälsa in their merger and subsequent sale to Meliva.

EY financial advisor in divestment of Helios Nordic Energy to VINCI

EY Corporate Finance advisor in the divestment of 100% of the shares in Helios Nordic Energy AB (“Helios”) to VINCI Concessions.

EY advisors to FrostPharma in their new partnership with Priveq

The Swedish entrepreneurial specialty pharma company FrostPharma welcomes Priveq as a new growth partner.

    Summary

    EY’s Corporate Finance team in the Health, Sciences & Wellness sector acted as financial advisers to the owners of Premicare in their sale to Prima Vård. EY teams were also involved in advising Premicare in transaction due diligence, tax and IT advice.

    About this article

    Authors